THE ANALYSIS OF INFLUENCE OF CLINICAL PREDICTORS ON THE RESULTS OF TREATMENT WITH ERLOTINIB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Salajka, Frantisek [1 ]
Pesek, Milos [2 ]
Krejci, Jana [3 ]
Skrickova, Jana [4 ]
Zatloukal, Petr
Koubkova, Leona
Grygarkova, Ivona
Hrnciarik, Michal [1 ]
Sticha, Michal [5 ]
机构：
[1] Univ Hosp, Dept Pneumol, Bulovka, Czech Republic
[2] Univ Hosp Plzen, Dept Pneumol, Plzen, Czech Republic
[3] Charles Univ Hosp Plzen, Dept Pneumol, Plzen, Czech Republic
[4] Univ Hosp Brno, Dept Resp Dis & Tb, Brno, Czech Republic
[5] Masaryk Univ, CS-60177 Brno, Czech Republic
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; erlotinib; clinical predictors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1293 / S1294
页数：2
相关论文
共 50 条
  • [1] Erlotinib treatment results in patients with advanced non-small-cell lung cancer (NSCLC)-Influence of clinical predictors
    Salajka, F.
    Pesek, M.
    Skrickova, J.
    Zatloukal, P.
    Koubkova, L.
    Grygarkova, Y.
    Hrnciarik, M.
    Hejduk, K.
    LUNG CANCER, 2012, 77 : S36 - S37
  • [2] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [3] The influence of clinical predictors on the results of treatment with erlotinib in patients with advanced NSCLC
    Salajka, Frantisek
    Pesek, Milos
    Krejci, Jana
    Skrickova, Jana
    Zatloukal, Petr
    Koubkova, Leona
    Grygarkova, Yvona
    Pavlik, Tomas
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S799 - S800
  • [4] Treatment of patients with advanced non-small-cell lung cancer (NSCLC) with erlotinib: results from clinical practice
    Faehling, M.
    Eckert, R.
    Kuom, S.
    Kamp, T.
    Stoiber, K.
    Kropf, C.
    Ruediger, S.
    Schumann, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 550 - 551
  • [5] Treatment of patients with advanced non-small-cell lung cancer (NSCLC) with erlotinib: results from clinical practice
    Faehling, Martin
    Eckert, Robert
    Kuom, Sabine
    Kamp, Torsten
    Stoiber, Kathrin
    Kropf, C.
    Ruediger, S.
    Schumann, Christian
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S711 - S712
  • [6] EXPERIENCE OF USING ERLOTINIB FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Kanazawa, Kenya
    Ishida, Takashi
    Suzuki, Aya
    Tachihara, Motoko
    Minemura, Hiroyuki
    Sekine, Satoko
    Oshima, Kengo
    Yokouchi, Hiroshi
    Watanabe, Kana
    Tanino, Yoshinori
    Munakata, Mitsuru
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1310 - S1310
  • [7] Cutaneous toxicity in erlotinib treatment for advanced non-small cell lung cancer (NSCLC)
    Bernabee, R.
    Cobo, M.
    Barneto, I.
    Valdivia, J.
    Fernandez, I.
    Rueda, A.
    Villatoro, R.
    de la Curz, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
    Platania, Marco
    Agustoni, Francesco
    Formisano, Barbara
    Vitali, Milena
    Ducceschi, Monika
    Pietrantonio, Filippo
    Zilembo, Nicoletta
    Gelsomino, Francesco
    Pusceddu, Sara
    Buzzoni, Roberto
    TARGETED ONCOLOGY, 2011, 6 (03) : 181 - 186
  • [9] Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
    Marco Platania
    Francesco Agustoni
    Barbara Formisano
    Milena Vitali
    Monika Ducceschi
    Filippo Pietrantonio
    Nicoletta Zilembo
    Francesco Gelsomino
    Sara Pusceddu
    Roberto Buzzoni
    Targeted Oncology, 2011, 6 : 181 - 186
  • [10] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
12345